. "Appendix B References." Assessment of the Role of Intermittent Preventive Treatment for Malaria in Infants: Letter Report. Washington, DC: The National Academies Press, 2008.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Assessment of the Role of Intermittent Preventive Treatment for Malaria in Infants: Letter Report
Chandramohan, D., J. Webster, L. Smith, T. Awine, S. Owusu-Agyei, and I. Carneiro. 2007. Is the Expanded Programme on Immunization the most appropriate delivery system for intermittent preventive treatment of malaria in West Africa? Trop Med Int Health 12(6):743-750.
Cisse, B., C. Sokhna, D. Boulanger, J. Milet, H. Ba el, K. Richardson, R. Hallett, C. Sutherland, K. Simondon, F. Simondon, N. Alexander, O. Gaye, G. Targett, J. Lines, B. Greenwood, and J. F. Trape. 2006. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: A randomised, placebo-controlled, double-blind trial. Lancet 367(9511):659-667.
Clyde, D. F., and G. T. Shute. 1957. Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals. Trans R Soc Trop Med Hyg 51(6):505-513.
Coulibaly, D., D. A. Diallo, M. A. Thera, A. Dicko, A. B. Guindo, A. K. Kone, Y. Cissoko, S. Coulibaly, A. Djimde, K. Lyke, O. K. Doumbo, and C. V. Plowe. 2002. Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali. Am J Trop Med Hyg 67(6):604-610.
Dalmiya, N., A. Palmer, and I. Darnton-Hill. 2006. Sustaining vitamin A supplementation requires a new vision. Lancet 368(9541):1052-1054.
Dicko, A., S. Sagara, M. S. Sissoko, O. Guindo, A. B. I. Diallo, M. Kone, M. A. Thera, M. Sacko, and O.K. Doumbo. 2004. Impact of intermittent preventive treatment with sulfadoxine pyrimethamine targetting the transmission season on the incidence of clinical malaria in children of 6 months to 10 years in Kambila, Mali. Am J Trop Med Hyg 71(4 Supplement):6.
Diourte, Y., A. Djimde, O. K. Doumbo, I. Sagara, Y. Coulibaly, A. Dicko, M. Diallo, M. Diakite, J. F. Cortese, and C. V. Plowe. 1999. Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali. Am J Trop Med Hyg 60(3):475-478.
Doumbo, O. K., K. Kayentao, A. Djimde, J. F. Cortese, Y. Diourte, A. Konare, J. G. Kublin, and C. V. Plowe. 2000. Rapid selection of Plasmodium falciparum dihydrofolate reductase mutants by pyrimethamine prophylaxis. J Infect Dis 182(3):993-996.
Emberger, M., A. M. Lechner, and B. Zelger. 2003. Stevens-Johnson syndrome associated with malarone antimalarial prophylaxis. Clin Infect Dis 37(1):e5-7.
García-Doval, I., L. LeCleach, H. Bocquet, X. L. Otero, and J. C. Roujeau. 2000. Toxic epidermal necrolysis and Stevens-Johnson syndrome: Does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 136(3):323-327.
Geerligs, P. D., B. J. Brabin, and T. A. Eggelte. 2003. Analysis of the effects of malaria chemoprophylaxis in children on haematological responses, morbidity and mortality. Bull WorldHealth Organ 81(3):205-216.